NCT00633919 - Efficacy of SLITone in House Dust Mite Allergic Patients | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions

Allergy

Interventions

BIOLOGICAL

SLITone(TM) Dermatophagoides mix

Sublingual immunotherapy with SLITone Dermatophagoides mix (200 STU) once daily for 2 years

BIOLOGICAL

Placebo

Sublingual immunotherapy once daily for 2 years

DRUG

Salbutamol inhaler

200 µg per puff; a short acting beta2-agonist (please refer to the 'detailed description' for details on the use)

DRUG

Budesonide/formoterol inhaler

80/4.5 µg per inhalation; a combination of inhaled corticosteroids and long acting beta2-agonist (please refer to the 'detailed description' for details on the use)

DRUG

Prednisone tablet

5 mg per tablet; oral corticosteroids (please refer to the 'detailed description' for details on the use)

DRUG

Desloratadine tablet

5 mg per tablet: anti-histamine (please refer to the 'detailed description' for details on the use)

DRUG

Budesonide nasal spray

64 µg per puff; inhaled corticosteroid (please refer to the 'detailed description' for details on the use)

Trial Locations (1)

Unknown

Fernando Rodríguez, Santander

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY